IC 108-2024: High Tibial Osteotomy: How to Get it Right and Avoid Complications (Case based lecture)

Availability

On-Demand

Expires on Sep 30, 2027

Cost

Member: $20.00

Resident/Fellow Member: $20.00

Affiliate Member: $20.00

Non-Member: $30.00

Credit Offered

1.5 CME Credits

1.5 Category A CEU Credits

Course Information
ADDITIONAL INFORMATION

This course includes the recording of a live Instructional Course from the 2024 AOSSM Annual Meeting which took place in Denver, CO.

IC 108: High Tibial Osteotomy: How to Get it Right and Avoid Complications (Case based lecture)

Course Description:

This course will look at several case-based lectures including:

Preoperative planning, traditional method, isolated high tibial osteotomy (Dr. Seth Sherman)
Understanding Complications and Avoiding them in HTO (Dr. Anil Ranawat)
Complex Tibial Osteotomies (Dr. Al Getgood)
Combined Tibial Femoral Osteotomies (Dr. Armando Vidal)

This course will review knee mal alignment with a special focus on osteotomy tips and common complications. Indications for these osteotomies such as how to avoid hinge fracture and properly manipulate slope will be discussed. The problems and pearls of each complication will be examined in a case-based discussion with special attention to preoperative planning and complex cases. Surgical techniques for osteotomies will be presented in case-based format.

Learning Objectives:

At the completion of this course, the participant will have:

A better understanding of treating knee osteoarthritis and malalignment as it pertains to complex cases.
A deeper understanding of diagnosis and surgical planning to apply an individualized plan to all cases.
A better understanding of the surgical technique for high tibial osteotomies, complex tibial osteotomies, and femoral osteotomies.

Faculty:

Anil S. Ranawat, MD
Alan M. Getgood, MD, FRCS (Tr&Orth
Seth L. Sherman, MD
Armando F. Vidal, MD

Accreditation

ACCREDITATION STATEMENT The American Orthopaedic Society for Sports Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Information

AMA CREDIT DESIGNATION STATEMENT The American Orthopaedic Society for Sports Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CLAIMING CREDIT In order to obtain AMA PRA Category 1 Credits™ participants must complete the activity and evaluation. Please note that this is an online-only activity. Participants must complete the activity and evaluation online. No hard copy submissions will be accepted.

ABOS MOC CREDIT STATEMENT: Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME requirements of the American Board of Orthopaedic Surgery’s (ABOS) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABOS credit.

The American Orthopaedic Society for Sports Medicine (AOSSM) (BOC AP#: P460) is approved by the Board of Certification, Inc. to provide continuing education for Athletic Trainers. This live activity is eligible for a maximum of 1.5 Category A hours/CEUs. ATs should claim only those hours actually spent in the educational program.

Disclosures

Name	Disclosure Details
Getgood, Alan (MD, FRCS (Tr&Orth))	Stock or Stock Options relationship with Precision OS; Stock or Stock Options relationship with Spring Loaded Technologies Inc; Paid Consultant relationship with Smith and Nephew; Stock or Stock Options relationship with Ostesys Inc; Stock or Stock Options relationship with LinkX Robotics; Research Support relationship with Smith and Nephew; Speaker's Bureau/Presenter relationship with Smith and Nephew
Ranawat, Anil (MD)	Paid Consultant relationship with BoneSupport; Paid Consultant relationship with NewClip; Paid Consultant relationship with Smith & Nephew; Paid Consultant relationship with Cervos; Unpaid Consultant relationship with Moximed; Stock or Stock Options relationship with Enhatch; Stock or Stock Options relationship with Conformis; Research Support relationship with Smith & Nephew; Paid Consultant relationship with Anika; Paid Consultant relationship with Xiros; Paid Consultant relationship with BodyCad
Sherman, Seth (MD)	Paid Consultant relationship with CONMED Linvatec; Paid Consultant relationship with Arthrex, Inc; Paid Consultant relationship with JRF Ortho; Royalties relationship with CONMED Linvatec; Paid Consultant relationship with Depuy J&J; Paid Consultant relationship with Kinamed; Paid Consultant relationship with LifeNet; Paid Consultant relationship with NewClip; Paid Consultant relationship with Ostesys; Paid Consultant relationship with Smith & Nephew; Paid Consultant relationship with Vericel; Paid Consultant relationship with Flexion; Stock or Stock Options relationship with Ostesys; Stock or Stock Options relationship with Reparel; Stock or Stock Options relationship with Sarcio; Stock or Stock Options relationship with Vivorte; Research Support relationship with Aesculap Biologics, LLC; Research Support relationship with Allosource; Research Support relationship with Miach Orthopaedics, Inc.; Research Support relationship with Organogenesis Inc.; Paid Consultant relationship with Enovis; Speaker's Bureau/Presenter relationship with JRF Ortho; Royalties relationship with DJO; Paid Consultant relationship with Linksys
Vidal, Armando (MD)	Unpaid Consultant relationship with BodyCad; Paid Consultant relationship with Stryker; Royalties relationship with stryker

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, we have implemented measures to identify and mitigate relevant financial relationships. All individuals in control of content have disclosed their financial relationships with ineligible companies within the past 24 months. These relationships have been reviewed and mitigated.

ORIGINAL RELEASE DATE: 10/01/2024
EXPIRATION DATE: 09/30/2027